Role of serological biomarkers in evaluating and predicting endoscopic activity in inflammatory bowel disease

Table 1 Patient characteristics after propensity matching, n (%)

	UC	CD	HCs	P value1	P value2	P value3
Number of subjects, n	330	270	85	-	-	-
Age, years, median (IQR)	48 (33, 59)	47 (31, 54)	49 (41, 60)	0.084	0.062	0.108
BMI, kg/m2, median (IQR)	23.84 (19.61, 24.37)	22.88 (18.40, 25.09)	24.59 (22.26, 28.73)	0.132	0.075	0.144
Gender
Male	174 (52.7)	156 (57.8)	44 (51.8)	0.480	0.327	0.129
Female	156 (47.3)	114 (42.2)	41 (48.2)
Duration of illness, years, median (IQR)	2 (0.6, 5)	1 (0.3, 3)	-
Endoscopic activity
Mild	122 (37.0)	137 (50.7)	-
Moderate	98 (29.7)	108 (40.0)	-
Severe	110 (33.3)	25 (9.3)	-

¹Represents ulcerative colitis group compared with healthy control group.

²Represents Crohn’s disease group compared with healthy control group.

³Represents ulcerative colitis group compared with Crohn’s disease group.

UC: Ulcerative colitis; CD: Crohn’s disease; HCs: Healthy controls; IQR: Interquartile range; BMI: Body mass index.